Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Pharmacorp Rx Inc. ( (TSE:PCRX) ) just unveiled an announcement.
PharmaCorp Rx Inc. has announced a C$15 million bought deal public offering, involving the sale of 35.7 million units at C$0.42 per unit. The proceeds from this offering will be used for future acquisition opportunities and general working capital requirements, potentially strengthening the company’s market position and expanding its network of community pharmacies.
More about Pharmacorp Rx Inc.
PharmaCorp Rx Inc. is a Canadian pharmacy acquisition and ownership platform that focuses on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners. The company is building a national network of community pharmacies under the PharmaChoice Canada banner, currently operating seven such pharmacies and planning to acquire more across Canada.
Average Trading Volume: 39,898
Technical Sentiment Signal: Sell
Current Market Cap: C$52.3M
See more insights into PCRX stock on TipRanks’ Stock Analysis page.